# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Goldman Sachs analyst Scott Fidel initiates coverage on Oscar Health (NYSE:OSCR) with a Neutral rating and announces Price ...
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Underweight and raises the price target from $1...
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...
Oscar Health (OSCR) is drawing comparisons to Hims & Hers (HIMS) as short sellers may trigger a moonshot with ACA subsidies...